Concepedia

Author

Sara Bystrup

Institut Català d'OncologiaORCID

Also Known As

Kathleen Imbach, S. Bystrup, Sara Bystrup, Sara Kjaergaard Bystrup

15

Publications

616

Citations

8

H-Index

12

Concepts

All Affiliations

Institut Català d'OncologiaInstitut d'Investigació en Ciències de la Salut Germans Trias i PujolHospital Universitari Germans Trias i PujolAarhus University HospitalBellvitge University Hospital
SB

About

Sara Bystrup is an author at Institut Català d'Oncologia specializing in tumor biology, oncology, and colorectal cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

58

2

Cell Biology

2

2

58

3

Tumor Biology

2

2

58

4

Pathology

1

1

20

5

Cancer Therapeutics

1

1

20

Sara Bystrup

×

7

Publications

274

Citations

7

H-Index

YearCitations

Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway

Vicenç Ruiz de Porras, Sara Bystrup, Anna Martínez‐Cardús,

Scientific Reports

2016

131

Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment

Vicenç Ruiz de Porras, Xieng C. Wang, Luís Palomero,

European Urology

2020

45

PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines

Alba Ginés, Sara Bystrup, Vicenç Ruiz de Porras,

PLoS ONE

2015

38

Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients

Vicenç Ruiz de Porras, Sara Bystrup, Sara Cabrero-de las Heras,

Cancers

2019

20

Isosteviol Has Beneficial Effects on Palmitate-Induced α-Cell Dysfunction and Gene Expression

Xiaoping Chen, Kjeld Hermansen, Jianzhong Xiao,

PLoS ONE

2012

18

Effects of Whey Proteins on Glucose Metabolism in Normal Wistar Rats and Zucker Diabetic Fatty (ZDF) Rats

Søren Gregersen, Sara Bystrup, Ann Overgaard,

The Review of Diabetic Studies

2013

12

Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: Preclinical and real-life clinical data

Adrià Bernat‐Peguera, Macedonia Trigueros, Angelica Ferrando‐Díez,

The Breast

2022

10

Page 1